Pre- and postnatal inflammatory mechanisms in chronic lung disease of preterm infants

Paediatric Respiratory Reviews

Volumn 5, Issue SUPPL. A, 2004, Pages

  Speer, Christian P ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease; Lung injury; Oxygen radicals; Proinflammatory cytokines; Proteases

Indexed keywords

CORTICOSTEROID; CYTOKINE; DEXAMETHASONE; HYDROCORTISONE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; MESSENGER RNA; OXYGEN; OXYGEN RADICAL; STEROID; VASCULAR CELL ADHESION MOLECULE 1; AUTACOID; LIPID; PROTEINASE;

AMNION FLUID; ARTICLE; ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; CELL ACTIVATION; CELL INFILTRATION; CHORIOAMNIONITIS; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CYTOKINE RELEASE; DISEASE ASSOCIATION; FETUS CIRCULATION; FETUS LUNG MATURATION; GASTROINTESTINAL HEMORRHAGE; GROWTH DISORDER; HOSPITAL INFECTION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INFLAMMATION; INFLAMMATORY CELL; LEUKOMALACIA; LIPID PEROXIDATION; LOW DRUG DOSE; LUNG ALVEOLUS EPITHELIUM; LUNG BLOOD VESSEL; LUNG INFECTION; LUNG INJURY; LUNG INTERSTITIUM; MACROPHAGE; NECROTIZING ENTEROCOLITIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEUTROPHIL; NEWBORN; NONHUMAN; OXYGEN TOXICITY; PATENT DUCTUS ARTERIOSUS; PATHOPHYSIOLOGY; PERINATAL PERIOD; PREMATURITY; PRENATAL PERIOD; PRIORITY JOURNAL; RESUSCITATION; RETROLENTAL FIBROPLASIA; UPREGULATION; ACUTE DISEASE; DISEASE COURSE; GROWTH INHIBITION; NEUTROPHIL CHEMOTAXIS; PNEUMONIA; PROTEIN EXPRESSION; REVIEW; VASCULARIZATION;

EID: 1342312491     PISSN: 15260542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1526-0542(04)90045-0     Document Type: Review

References (31)

1. Speer CP. New insights into the pathogenesis of pulmonary inflammation in preterm infants. Biol Neonate 2001; 79: 205-209.
2. Yoon BH, Romero R, Kim KS, Park JS, Ki SH, Kim BI, Jun JK. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1999; 181(4): 773-779.
3. Groneck P, Schmale J, Soditt V, Stützer J, Goetze-Speer B, Speer CP. Bronchoalveolar inflammation following airway infection in preterm infants with chronic lung disease. Pediatr Pulmonol 2001; 31: 331-338.
4. Bancalari E. Changes in the pathogenesis and prevention of chronic lung disease of prematurity. Am J Perinatol 2001; 18: 1-9.
5. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-1729.
6. Groneck P, Goetze-Speer B, Oppermann M, Eiffert H, Speer CP. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high risk preterm infants. Pediatrics 1994; 93: 712-718.
7. Little S, Dean T, Bevin S, Hall M, Ashton M, Church M, Warner J, Shute J. Role of elevated plasma soluble ICAM-1 and bronchial lavage fluid IL-8 levels as markers of chronic lung disease in premature infants. Thorax 1995; 50: 1073-1079.
8. Kotecha S, Silverman M, Shaw RJ, Klein M. Soluble L-selectin concentrations in bronchoalveolar fluid obtained from infants who develop chronic lung disease. Arch Dis Child 1998; 78: F143-147.
9. Brus F, van Oeveren W, Okken A, Bambang Oetomo S. Activation of circulating polymorphonuclear leukocytes in preterm infants with severe idiopathic respiratory distress syndrome. Pediatr Res 1996; 39: 456-463.
10. Saugstad OD, Buo L, Johansen HT, et al. Activation of the plasma kallikrein-kinin system in respiratory distress syndrome. Pediatr Res 1992; 32: 431-435.
11. Jaarsma AS, Braaksma MA, Geven WB, van Oeveren W, Oetomo SB. Early activation of inflammation and clotting in the preterm lamb with neonatal RDS: Comparison of conventional ventilation and high frequency oscillatory ventilation. Pediatr Res 2001; 50: 650-657.
12. Ferreira JP, Bunch TJ, Albertine KH, Carlton DP. Circulating neutrophil concentration and respiratory distress in premature infants. J Pediatr 2000; 136: 466-472.
13. Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J. Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 2001; 107: 1529-1536.
14. Murch SH, Costeloe K, Klein NJ, Rees H, McIntosh N, Keeling JW, MacDonald TT. Mucosal tumor necrosis factor-α production and extensive disruption of sulfated glycosaminglycans begin within hours of birth in neonatal respiratory distress syndrome. Pediatr Res 1996; 40: 484-489.
15. Jones CA, Cayabyab RG, Kwong KY, Stotts C, Wong B, Hamdan H, Minoo P, DeLemos RA. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996; 39: 966-975.
16. Speer CP, Ruess D, Harms K, Herting E, Gefeller O. Neutrophil elastase and acute pulmonary damage in neonates with severe respiratory distress syndrome. Pediatrics 1993; 91: 794-799.
17. Saugstad OD. Chronic lung disease: oxygen dogma revisited. Acta Paediatr 2001; 90: 113-115.
18. Gerber CE, Bruchelt G, Stegmann H, Schweinsberg F, Speer CP: Presence of bleomycin-detectable free iron in the alveolar system of preterm infants. Biochem Biophys Res Com 1999; 257: 218-222.
19. Gerber CE, Bruchelt G, Götze-Speer B, Speer CP. Detection by ELISA of low transferring levels in bronchoalveolar secretions of preterm infants. J Immunol Meth 2000; 233: 41-45.
20. Schock BC, Sweet DG, Halliday HL, Young IA, Ennis M. Oxidative stress in lavage fluid of preterm infants at risk of chronic lung disease. AJP 2001; 281: L1386-L1391.
21. Cederqvist K, Sorsa T, Tervahartiala T, Maisi P, Reunanen K, Lassus P, Andersson S. Matrix metalloproteinases-2, -8, and -9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress. Pediatrics 2001; 108: 686-692.
22. Schock BC, Sweet DG, Ennis M, Warner JA, Young AS, Halliday HL. Oxidative stress and increased type-IV collagenase levels in bronchoalveolar lavage fluid from newborn babies. Pediatr Res 2001; 50: 29-33.
23. Kotecha S, Wangoo A, Silverman M, Shaw RJ. Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity. J Pediatr 1996; 128: 464-9.
24. Lecart C, Cayabyab R, Buckley S, Morrison J, Kwong KY, Warburton D, Ramanathan R, Jones CA, Minoo P. Bioactive transforming growth factor-beta in the lungs of extremely low birthweight neonates predicts the need for home oxygen supplementation. Biol Neonate 2000; 77: 217-223.
25. Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, Kim BI. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997; 177(4): 825-830.
26. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998; 179: 194-202.
27. Craven CM, Ward K. Fetal endothelial cells express vascular cell adhesion molecule in the setting of chorioamnionitis. Am J Reprod Immunol 2000; 43: 259-263.
28. Schmidt B, Cao L, Mackensen-Haen S, Kendziorra H, Klingel K, Speer CP. Chorioamnionitis and inflammation of the fetal lung. Am J Obstet Gynecol 2001; 194: 173-177.
29. Kramer BW, Kramer S, Ikegami M, Jobe AH. Injury inflammation and remodelling in fetal sheep lung after intraamniotic endotoxin. Am J Physiol 2002. In press.
30. Lassus P, Turanlahti M, Heikkilä P, Anderssen LC, Nupponen I, Sarnesto A, Andersson S. Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 2001; 164: 1981-1987.
31. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1 and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 164: 1971-1980.